文献速递糖尿病

晚发2型糖尿病患者的胰腺萎缩与胰岛淀粉样沉积

Pancreas Atrophy and Islet Amyloid Deposition in Patients With Elderly-Onset Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

研究对比了晚发2型糖尿病(eT2DM)与中年发病2型糖尿病(mT2DM)等组的胰腺病理,发现eT2DM组胰腺重量较其他组减少近50%,伴导管阻塞、腺泡萎缩、纤维化及胰岛淀粉样沉积,胰岛质量显著降低,淀粉样物容积密度与β细胞容积密度呈负相关,而与体质指数无关。

要点

  • eT2DM组胰腺重量较其他组减少近50%,伴导管上皮增生、腺泡萎缩和纤维化。
  • eT2DM组胰岛质量显著降低,胰岛淀粉样沉积与β细胞容积密度呈负相关。
  • eT2DM组血清淀粉酶轻度升高,但无胰腺炎的临床表现。

核心结论

  • eT2DM不同于mT2DM,其特征为胰腺萎缩、导管病变和淀粉样沉积。

研究设计与样本

  • 研究纳入13例年轻非糖尿病者(20至29岁)、27例mT2DM患者(45至87岁)、22例中年无T2DM者、15例eT2DM患者(85至100岁)和30例老年无T2DM者,对胰腺进行常规显微镜观察及免疫染色切片的形态计量分析。

主要发现

  • eT2DM组估计糖尿病发病年龄为80.8±1.4岁(均值±标准误),mT2DM组为48.3±2.4岁。
  • eT2DM组胰腺重量较其他组减少近50%,显示导管阻塞伴上皮增生、明显腺泡萎缩、纤维化及胰岛淀粉样沉积。
  • eT2DM组胰岛质量显著降低。
  • eT2DM组淀粉样物容积密度与β细胞容积密度呈负相关,而与体质指数无关。
  • eT2DM组实验室检查显示血清淀粉酶轻度升高,但无明显的胰腺炎临床体征和症状。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: With prolonged life expectancy, we often encounter patients with elderly-onset type 2 diabetes mellitus (eT2DM). Although the clinical features of eT2DM are suggested to be different from those in patients with middle-age-onset type 2 diabetes mellitus (mT2DM), the islet pathologic features in eT2DM have not been addressed. OBJECTIVE: We attempted to characterize the pancreatic pathology in eT2DM and sought its clinical implications. MATERIALS AND METHODS: Pancreata from 13 young nondiabetic (age, 20 to 29 years), 27 patients with mT2DM (age, 45 to 87 years), 22 middle-age subjects without T2DM, 15 subjects with eT2DM (age, 85 to 100 years), and 30 elderly subjects without T2DM were investigated. Together with conventional microscopic observations, morphometric analysis on the islet, islet endocrine cells, and amyloid deposition was conducted on immunostained sections. RESULTS: The estimated age of diabetes onset was 80.8 ± 1.4 years (mean ± standard error) in the eT2DM group and that of the mT2DM group was 48.3 ± 2.4 years. The pancreatic weight was nearly 50% less in the eT2DM group than in the other groups, showing duct obstruction with epithelial hyperplasia, marked acinar atrophy, fibrosis, and amyloid deposition in the islet. The islet mass was significantly reduced in the eT2DM group. The amyloid volume density correlated inversely with the β-cell volume density but not with the body mass index in the eT2DM group. Laboratory data showed mild elevation of serum amylase in the eT2DM group, although clinical signs and symptoms of pancreatitis were not apparent. CONCLUSIONS: eT2DM is distinct from mT2DM and characterized by pancreas atrophy, ductal lesions, and amyloid deposition.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Xin A, Mizukami H, Inaba W, et al. Pancreas Atrophy and Islet Amyloid Deposition in Patients With Elderly-Onset Type 2 Diabetes. J Clin Endocrinol Metab. 2017. PMID: 28505316. doi:10.1210/jc.2016-3735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。